Trial · NCT00433160
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 52-Week Double-Blind (DB) Period | STARTED | Teriparatide | 137 | |
| 52-Week Double-Blind (DB) Period | STARTED | Placebo | 70 | |
| 52-Week Double-Blind (DB) Period | Received Treatment | Teriparatide | 136 | |
| 52-Week Double-Blind (DB) Period | Received Treatment | Placebo | 68 | |
| 52-Week Double-Blind (DB) Period | COMPLETED | Teriparatide | 120 | |
| 52-Week Double-Blind (DB) Period | COMPLETED | Placebo | 60 | |
| 52-Week Double-Blind (DB) Period | NOT COMPLETED | Teriparatide | 17 | |
| 52-Week Double-Blind (DB) Period | NOT COMPLETED | Placebo | 10 | |
| 76 Weeks, 24-Week Open Label (OL) Period | STARTED | Teriparatide | 119 | |
| 76 Weeks, 24-Week Open Label (OL) Period | STARTED | Placebo | 59 | |
| 76 Weeks, 24-Week Open Label (OL) Period | Received Treatment | Teriparatide | 119 | |
| 76 Weeks, 24-Week Open Label (OL) Period | Received Treatment | Placebo | 59 | |
| 76 Weeks, 24-Week Open Label (OL) Period | COMPLETED | Teriparatide | 113 | |
| 76 Weeks, 24-Week Open Label (OL) Period | COMPLETED | Placebo | 55 | |
| 76 Weeks, 24-Week Open Label (OL) Period | NOT COMPLETED | Teriparatide | 6 | |
| 76 Weeks, 24-Week Open Label (OL) Period | NOT COMPLETED | Placebo | 4 | |
| 104 Weeks, 28-Week OL Period | STARTED | Teriparatide | 102 | |
| 104 Weeks, 28-Week OL Period | STARTED | Placebo | 50 | |
| 104 Weeks, 28-Week OL Period | Received Treatment | Teriparatide | 102 | |
| 104 Weeks, 28-Week OL Period | Received Treatment | Placebo | 50 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00433160/flow